ZERVIATE Trademark

Trademark Overview

On Thursday, August 2, 2018, a trademark application was filed for ZERVIATE with the United States Patent and Trademark Office. The USPTO has given the ZERVIATE trademark a serial number of 88063436. The federal status of this trademark filing is REGISTERED as of Tuesday, November 3, 2020. This trademark is owned by NICOX SA. The ZERVIATE trademark is filed in the Pharmaceutical Products category with the following description:

ocular pharmaceuticals; ophthalmic and ophthalmological preparations; pharmaceutical products for ophthalmological use; solutions for lubrication and rewetting the eyes; eye drops; solutions for ocular hydration; solutions for reducing ocular inflammation and pain associated with ocular pathologies; solutions for reducing symptoms associated with conjunctivitis; pharmaceutical preparations for the prevention and treatment of eye disorders, diseases and conditions; solutions and preparations for treating pathologies of the eyelids and eyelid margins; pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists
zerviate

General Information

Serial Number88063436
Word MarkZERVIATE
Filing DateThursday, August 2, 2018
Status700 - REGISTERED
Status DateTuesday, November 3, 2020
Registration Number6190318
Registration DateTuesday, November 3, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2019

Trademark Statements

Goods and Servicesocular pharmaceuticals; ophthalmic and ophthalmological preparations; pharmaceutical products for ophthalmological use; solutions for lubrication and rewetting the eyes; eye drops; solutions for ocular hydration; solutions for reducing ocular inflammation and pain associated with ocular pathologies; solutions for reducing symptoms associated with conjunctivitis; pharmaceutical preparations for the prevention and treatment of eye disorders, diseases and conditions; solutions and preparations for treating pathologies of the eyelids and eyelid margins; pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 23, 2019
Primary Code005
First Use Anywhere DateMonday, March 23, 2020
First Use In Commerce DateMonday, March 23, 2020

Trademark Owner History

Party NameNICOX SA
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressValbonne 06560
FR
Party NameNICOX SA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressValbonne 06560
FR
Party NameNICOX SA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressValbonne 06560
FR

Trademark Events

Event DateEvent Description
Wednesday, May 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 17, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, May 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 16, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, May 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 3, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, September 26, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 25, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, September 5, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, August 21, 2020USE AMENDMENT FILED
Saturday, September 5, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 21, 2020TEAS STATEMENT OF USE RECEIVED
Friday, January 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 29, 2020SOU EXTENSION 1 GRANTED
Wednesday, January 29, 2020SOU EXTENSION 1 FILED
Wednesday, January 29, 2020TEAS EXTENSION RECEIVED
Tuesday, August 27, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 23, 2019ASSIGNED TO LIE
Saturday, May 18, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, May 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 15, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 14, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 14, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 26, 2018NON-FINAL ACTION E-MAILED
Monday, November 26, 2018NON-FINAL ACTION WRITTEN
Tuesday, November 20, 2018ASSIGNED TO EXAMINER
Thursday, August 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 6, 2018NEW APPLICATION ENTERED

Related Keywords

zerviate solutions ocular preparations pharmaceutical disorders associated reducing treatment pathologies ophthalmological